
Sign up to save your podcasts
Or


Today’s episode will be focusing on primary brain tumors within neuro-oncology. We will primarily be discussing the classification of gliomas and management, including oligodendrogliomas, ependymomas, astrocytomas, and glioblastoma multiforme (GBM).
This week’s episode will be focusing on Chronic Lymphocytic Leukemia (CLL) for health care providers. We will go over all the important details on presentation, diagnosis, prognostic factors, and treatment options.
This week’s episode will be focusing on neuroendocrine tumors (NET), their characteristics, diagnosis, associated syndromes, and focus mostly on gastro-enteropancreatic NETs.
This week’s episode will be focusing on details of the hematology & oncology board exams, how we prepared the days leading up to our exam, and we cover some highly tested topics in both hematology & oncology. We wish the best of luck to everyone taking their boards this year!
This week’s episode will be focusing on Cervical Cancer facts for health care providers. We will go over important details on prevention, risk factors, diagnosis & NCCN category 1 treatments.
This week’s episode will be focusing on porphyrias, we will go over quick facts on the need to know facts regarding acute & chronic porphyrias from presentation to treatment.
This week’s episode will be focusing on Chronic Myeloid Leukemia or CML for health care providers. We will go over all the important details on the genetics of CML, diagnosis and treatment algorithms.
October marks Breast Cancer Awareness Month & this week’s episode is the last of 3 episodes covering breast cancer facts for health care providers. We will go over the NCCN guidelines for systemic therapy related to metastatic breast cancer, as well as common side effects of these therapies.
October marks Breast Cancer Awareness Month & this week’s episode is part 2 of 3 covering breast cancer facts for health care providers. This will summarize treatment options for localized breast cancer. We will go over important details on indications for radiation, as well as systemic therapies based on the ER/PR/her-2 receptor status.
From the publisher's feed

322 Listeners

496 Listeners

39 Listeners

121 Listeners

56 Listeners

3,425 Listeners

1,197 Listeners

187 Listeners

46 Listeners

516 Listeners

366 Listeners

51 Listeners

58 Listeners

51 Listeners

46 Listeners